Health
Vaccine Market Dominated By Multinationals In The Absence Of Strong Local Producer
The vaccine business is worth about EUR30 million a year, with sales of tree million units. Despite it being a small market, international companies such as Sanofi and GlaxoSmithKline (GSK)...
Farmaceutica Remedia Eyes 61% Hike In ‘12 Gross Profit, To RON8.7M
Romanian medicine wholesaler Farmaceutica Remedia Deva (RMAH.RO) expects a pretax profit of 8.7 million lei (EUR1.98 million) this year, up 61% from RON5.41 million in the previous year.
ANZAG Buys A Further 20% In Farmexpert
German drug wholesaler ANZAG, with annual turnover of over EUR4 billion, has bought 20% of Farmexpert from businessman Eugen Banciu, the company's founder, increasing its participation to 80...
Family-Owned Arcadia Group Posts EUR8 Million Revenue From Medical Services
The Arcadia group based in Iasi (NE Romania), which comprises Arcadia Hospital, Arcadia Policlinic and Arcadia Cardio, controlled by the Fiterman family, posted EUR7.7 million turnover in 20...
Head Of Novartis: Prospects Are Better In Romania Than In Western Countries
Novartis Pharma Services general manager Elena Mitova said prospects are very good in Romania, adding that she prefers to be here, where potential is bigger than on western markets, which ha...
GlaxoSmithKline’s Romanian Plant Reaches EUR100M Turnover
Europharm Brasov, the drug plant of UK giant GlaxoSmithKline, ended last year with turnover of around EUR100 million, up by around 10% on 2010.
GSK Romania Sales Up 11% In 2011, To EUR151.8M
GSK Romania, the local branch of British drugmaker GlaxoSmithKline (GSK), posted sales of EUR151.8 million last year, up 11% from 2010, according to the Cegedim data cited by the company.
Top 10 Private Clinic Networks Made More Than EUR200 Million In Revenue Last Year, Up 15% On 2010
Private medical services, one of the most dynamic sectors of the economy, continued to grow last year, making the top ten players more than EUR200 million in revenue, almost half of the enti...
Ropharma Eyes 20% Higher Profit In 2012
Romanian generic drugs wholesaler Ropharma Brasov estimates its net profit will rise 20% to 12.8 million lei (EUR2.9 million) in 2012, supported by a 12% increase in sales.